Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Community pharmacy 

PCNs will be 'required' to involve community pharmacy from April 2020, says NHS England

All primary care networks (PCNs) will be required to collaborate with community pharmacies from April 2020, NHS England has said.

In guidance for local pharmaceutical committees, published on 17 June 2019, NHS England outlined how PCNs could involve community pharmacies, adding that “collaboration with non-GP providers, such as community pharmacies, will be a requirement for PCNs from April 2020”.

The guidance added that it expects each PCN to include an average of between 10 and 11 community pharmacies.

While the guidance said the exact role that community pharmacies “will take in each PCN will be for individual networks and their local community pharmacies to agree”, it outlined four possibilities.

These included offering the newly expanded GP Digital Minor Illness Referral Service (DMIRS), which was launched in 54 pharmacies and 26 GP practices across England in June 2019.

The GP DMIRS is expected to “provide a network-based referral route for patients with minor illnesses,” NHS England’s guidance said.

It added that community pharmacies could also take the lead on delivering public health campaigns within the network and “help deliver against the service specifications in the GP contract in areas such as CVD [cardiovascular disease] detection and around awareness of cancer symptoms and promoting early diagnosis”.

PCNs were first announced in the ‘NHS Long Term Plan’ and each one is expected to serve 30,000–50,000 patients from 1 July 2019.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206689

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.